Johnes Disease Diagnostics Market – By Test Type, Animal Type, Global Forecast, 2024 – 2032

Johne’s Disease Diagnostics Market Size

The global Johne’s disease diagnostics market size was valued at USD 645.6 million in 2023 and is poised to grow at 5.2% CAGR from 2024 to 2032. The market is experiencing significant growth, driven by increasing awareness about the disease and its impact on livestock health and productivity.
 

Johne’s disease, caused by Mycobacterium avium subspecies paratuberculosis (MAP), is a chronic gastrointestinal infection primarily affecting cattle, sheep, and goats. As more livestock producers recognize the financial implications of infected animals, the demand for effective animal diagnostics has surged.
 

Recent data from the USDA's National Animal Health Monitoring System (NAHMS) indicates that Johne's disease affects approximately 68% of U.S. dairy herds, with economic losses estimated at USD 200 to 250 million annually. In Europe, a 2022 study published in the Journal of Dairy Science reported prevalence rates ranging from 20% to 50% in various countries. These statistics underscore the growing need for advanced diagnostic solutions in the global livestock industry.
 

Furthermore, advancements in diagnostic technologies, including PCR and serological tests, have enhanced the accuracy and speed of diagnosis. These improvements make diagnostic methods more attractive to veterinarians and livestock producers. Additionally, the increasing focus on animal welfare and sustainable farming practices has prompted producers to adopt reliable diagnostic techniques for identifying and managing infected animals. As a result, these factors collectively contribute to the expansion of the Johne’s disease diagnostics market.
 

Johne's disease diagnostics employ multiple techniques to identify MAP, including Enzyme-Linked Immunosorbent Assay (ELISA) for antibody detection and Polymerase Chain Reaction (PCR) to identify MAP DNA in fecal samples. Timely and precise diagnosis is crucial for managing disease transmission and reducing economic impacts on livestock industries.

 

Johne’s Disease Diagnostics Market Trends

• Eradication programs and increased awareness of paratuberculosis are driving growth in the market.
  • For instance, the Irish Johne's Control Programme (IJCP) demonstrates a comprehensive approach to managing the disease in Ireland's cattle industry. As of 2021, over 1,800 herds were enrolled in the program, representing approximately 15% of the country's dairy herds.
     
  • The program enhances biosecurity, improves calf health, and demonstrates Ireland's commitment to sustainable cattle production. This approach necessitates regular testing, increasing the demand for accurate diagnostic tools for disease management.
     
• In the U.S., the USDA's Animal and Plant Health Inspection Service (APHIS) has implemented a cooperative Federal-State-Industry Johne's Disease Control Program. According to USDA estimates, Johne's disease affects approximately 68% of U.S. dairy herds, resulting in an annual economic loss of USD 200 to 250 million for the dairy industry.
   
• Increased funding for research to develop new control measures further highlights growing awareness of Johne's disease. The USDA's National Institute of Food and Agriculture (NIFA) allocated over USD 5 million in grants for Johne's disease research between 2015 and 2020.
   
• These initiatives reflect the growing recognition of paratuberculosis as a major concern in livestock health, fueling the demand for diagnostic kits, and thereby propelling market growth.
   

Johne’s Disease Diagnostics Market Analysis

Based on test type, the market is classified into Enzyme-Linked Immunosorbent Assay (ELISA), Polymerase Chain Reaction (PCR), and Agar Gel Immunodiffusion (AGID). The PCR segment dominated the market with 45.3% of the market share in 2023.
 

• The significant growth of this segment can be attributed to its high accuracy, sensitivity, and ability to detect Mycobacterium avium subspecies paratuberculosis (MAP) at an early stage.
   
• Additionally, advancements in PCR technologies have made it more accessible, cost-effective, and user-friendly for veterinary diagnostics, driving its widespread adoption.
   
• Furthermore, with the rising awareness of Johne's disease's economic impact on livestock production and the increasing demand for reliable diagnostic tools, the PCR segment has emerged as the preferred choice, ensuring its dominant position in the market.
   

Based on animal type, the Johne’s disease diagnostics market is segmented into cattle, goats, sheep, and other animal types. The cattle segment accounted for USD 581.7 million in 2023.
 

• Cattle, particularly dairy herds, are highly susceptible to Mycobacterium avium subspecies paratuberculosis (MAP), the causative agent of Johne's disease. This widespread occurrence has driven the demand for diagnostic solutions in the cattle segment.
   
• The significant impact of the disease on cattle, leading to reduced milk production, weight loss, and overall poor health in infected animals, ultimately causes substantial economic losses in the dairy and beef industries.
   
• Thus, early detection through diagnostics is essential for managing the disease and minimizing its impact, contributing to segmental growth.
   

The North America Johne’s disease diagnostics market was valued at USD 271.8 million in 2023 and is expected to grow lucratively at a 5.1% CAGR over the analysis period.
 

• North America holds a significant market share in the market due to the region's advanced veterinary infrastructure, increased awareness among livestock producers, and strong regulatory support for disease control.
   
• Additionally, rising consumer demand for safe, high-quality meat products further enhances market growth. For instance, according to the National Institutes of Health (NIH), Americans aged 2 years and older consume an average of 42.2 grams (1.5 ounces) of beef per day. This high consumption rate emphasizes the importance of maintaining healthy cattle herds, as diseases like Johne's can significantly impact beef production. Consequently, effective diagnostic tools are essential for managing Johne's disease and ensuring a consistent beef supply.
   
• These factors are expected to contribute to the continued growth of the market in North America.
   

The U.S. Johne’s disease diagnostics market accounted for USD 248.7 million in 2023 and is projected to reach USD 380.9 million by 2032.
 

• Strong government initiatives promoting routine testing, herd management plans, and risk assessments to effectively combat Johne’s disease support the growth of this market.
   
• Furthermore, the market is bolstered by the widespread adoption of advanced diagnostic technologies, such as PCR and ELISA, which significantly enhance the sensitivity and speed of disease detection.
   
• Together, these factors create a robust environment for the growth of the market in the U.S. over the coming years.
   

The China Johne’s disease diagnostics market is anticipated to experience remarkable growth over the forecast period.

• According to the China Animal Health and Epidemiology Center, the prevalence of Johne's disease in Chinese dairy herds increased from 2.5% in 2015 to 3.8% in 2020. This increase in prevalence highlights the growing need for effective Johne's disease diagnostics, potentially driving market growth in this sector.
   
• Additionally, increasing awareness among farmers and veterinarians about the importance of early Johne's disease detection is contributing to market growth. A 2022 survey by the Chinese Veterinary Medical Association found that 72% of livestock veterinarians now consider Johne's disease testing essential, compared to 58% in 2018. This growing recognition of the importance of Johne's disease testing is expected to drive demand for diagnostic products and services, benefiting the overall market.
   

India is expected to showcase significant growth in the global Johne’s disease diagnostics market.
 

• According to the 20th Livestock Census, India's total bovine population, including cattle, buffalo, gayal/ Drung ox, and yak, reached 302.79 million in 2019, marking a 1.0% increase from the previous census. This indicates a growing livestock sector that requires effective disease management solutions, including diagnostics for Johne’s disease.
   
• As the demand for healthy livestock and high-quality dairy products rises, there is a corresponding need for advanced diagnostic tools to monitor and control disease outbreaks, driving significant growth in the market.
   

Johne’s Disease Diagnostics Market Share

The market is witnessing a robust competitive landscape, characterized by the presence of several key players, each striving to capture a significant market share. This market share is largely driven by advancements in diagnostic technologies, including PCR and ELISA, which enhance the accuracy and speed of disease detection. Companies such as Thermo Fisher Scientific, VMRD, and IDEXX Laboratories lead the market by offering innovative diagnostic solutions and expanding their product portfolios to include tests for various livestock species, including cattle and goats.
 

Johne’s Disease Diagnostics Market Companies

Prominent players operating in the Johne’s disease diagnostics industry include:

• BioMerieux SA
• Idexx Laboratories, Inc.
• INDICAL BIOSCIENCE GmbH
• Innovative Diagnostics (IDvet)
• MV Diagnostics
• Pictor diagnostics
• Tetracore, Inc.
• Thermo Fisher Scientific Inc.
• VMRD, Inc.
• Zoetis Inc.
   

Johne’s Disease Diagnostics Industry News:

• In July 2020, VMRD received USDA approval to test goat serum with their Johne’s antibody test kit. This new development adds to the existing USDA licensure for bovine serum and milk samples, which are already utilized in laboratories throughout the U.S. and globally. This helped the company diversify its product offerings, enabling them to cater to a broader range of livestock species.
   

The Johne’s disease diagnostics market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD Million from 2021 – 2032 for the following segments:

Click here to Buy Section of this Report

Market, By Test Type

• Enzyme-Linked immunosorbent assay (ELISA)
• Polymerase chain reaction (PCR)
• Agar gel immunodiffusion (AGID)

Market, By Animal Type

• Cattle
• Goat
• Sheep
• Other animal types

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Netherlands
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa